MorphoSys AG
$18.02
24H
Market Cap
Volume
Supply
Price Chart
About MorphoSys AG - MOR
MorphoSys AG is a biopharmaceutical company that focuses on the development and commercialization of antibodies for both therapeutic and diagnostic applications. Based in Germany, the company employs proprietary technologies to design and produce human antibodies for a variety of medical needs.
What are MorphoSys AG's core values and mission statement?
As of the last available information, MorphoSys AG's mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Their core values emphasize a commitment to science, pioneering spirit, collaboration, and integrity.
Who founded MorphoSys AG and when?
MorphoSys AG was founded by Dr. Simon Moroney and Dr. Andreas Plückthun in 1992.
Who leads MorphoSys AG?
As of my last update, Jean-Paul Kress is the CEO of MorphoSys AG.
Where is MorphoSys AG located, and what is its base country?
MorphoSys AG is located in Planegg, Germany, and its base country is Germany.
On which exchanges is MorphoSys AG traded?
MorphoSys AG is traded on the Frankfurt Stock Exchange under the ticker symbol MOR and on the NASDAQ under the symbol MOR.
Historical data
MorphoSys AG (MOR) Price Live Data
The live price of MorphoSys AG (MOR) is $18.02, with a trading volume of 539,031 in the last 24 hours. Wrapstocks updates the MOR price in real-time. MorphoSys AG is down -0.11% in the last 24 hours. The company has a live market cap of $2,710,316,288.00 and a supply of 150,406,009 MOR stocks.
MorphoSys AG (MOR) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 6 hours and 14 minutes.
